Search Results
Found 3 results
510(k) Data Aggregation
(154 days)
The Pantheris LV System is indicated to remove plaque (atherectomy) from partially occluded native or restenotic vessels, including in-stent restenosis (ISR), in the peripheral vasculature with a reference diameter of 3.0 mm, using OCT-assisted orientation and imaging. The system is an adjunct to fluoroscopy by providing images of vessel lumen, wall structures, and vessel morphologies. The Pantheris LV System is NOT intended for use in the iliac, coronary, cerebral, renal or carotid vasculature.
The Pantheris LV catheter combines the use of Avinger's optical coherence tomography (OCT) technology with peripheral vascular atherectomy capabilities. The Pantheris LV System consists of the Pantheris LV catheter, a Lightbox Sled with integrated umbilical (referred to as "Sled"), and the Lightbox Imaging Console (referred to as "Lightbox"). The Pantheris LV catheter is a 7 French device with a working length of 110 cm. It is comprised of two components-an outer support catheter and an inner assembly or drive shaft. It is provided sterile and is a single-use device compatible with 5 Fr vascular sheaths. The Pantheris LV catheter incorporates an optical fiber that allows real-time diagnosis of vessel condition and morphology as well as OCT-guided atherectomy during the procedure with its connection to the Lightbox.
This document is a 510(k) summary for the Pantheris LV Atherectomy Catheter. It outlines the device's indications for use, compares it to predicate and reference devices, and describes the performance data used to demonstrate substantial equivalence.
Based on the provided text, the Pantheris LV Atherectomy Catheter is not an AI/ML enabled device. This conclusion is drawn from the following observations:
- Absence of AI/ML terminology: The document does not mention any terms typically associated with AI or machine learning, such as "algorithm," "model," "deep learning," "neural network," "AI assistance," "inference," "training data," "validation data," "ground truth establishment" for algorithms, or "performance metrics" relevant to AI (e.g., sensitivity, specificity, AUC for an AI-driven diagnostic).
- Focus on mechanical and optical characteristics: The device description and performance data sections primarily detail mechanical properties, optical coherence tomography (OCT) imaging capabilities (which are optical imaging not AI-driven image interpretation), electrical safety, electromagnetic compatibility, and biocompatibility.
- Comparison to existing devices based on physical design: The substantial equivalence argument relies heavily on comparing the Pantheris LV's physical design attributes (e.g., catheter size, tip length, working length, mechanism of atherectomy) and shared operational characteristics with existing cleared devices, rather than any advanced computational functionalities.
- Nature of the device: The device is described as an "atherectomy catheter" used to "remove plaque." Its functionality involves physical plaque removal assisted by OCT imaging for guidance, not AI-driven diagnosis, interpretation, or decision-making. The OCT is explicitly stated as "OCT-assisted orientation and imaging" and "an adjunct to fluoroscopy by providing images of vessel lumen, wall structures, and vessel morphologies," referring to human interpretation of these images, not AI analysis of them.
- Lack of AI-specific study types: The "Performance Data" section details mechanical, electrical, and biocompatibility testing. There is no mention of studies that would be typical for an AI/ML device, such as those evaluating diagnostic accuracy (e.g., standalone performance, MRMC studies, reader studies). The sections on "Animal Testing" and "Clinical Studies" explicitly state they "were not necessary" for this particular submission, further indicating the absence of complex data-driven (AI) performance validation.
Therefore, the request to describe acceptance criteria and study data for an AI/ML device is not applicable to the Pantheris LV Atherectomy Catheter based on this document. The provided text does not contain information related to AI/ML acceptance criteria or studies.
Ask a specific question about this device
(139 days)
The Pantheris System is intended to remove plaque (atherectomy) from partially occluded native or restenotic vessels, including in-stent restenosis (ISR), in the peripheral vasculature with a reference diameter of 3.0 mm to 7.0 mm, using OCT-assisted orientation and imaging. The system is an adjunct to fluoroscopy by providing images of vessel lumen, wall structures, and vessel morphologies. The Pantheris system is not intended for use in the iliac, coronary, cerebral, renal or carotid vasculature.
The Pantheris System consists of a Pantheris atherectomy catheter, a Lightbox Sled with integrated umbilical (referred to as "Sled"), and a Lightbox HS Imaging Console (referred to as "Lightbox"). The Pantheris atherectomy catheter is a 7 French device with a working length of 110 cm. It incorporates an optical fiber that allows real-time diagnosis of vessel condition and morphology as well as OCT-guided atherectomy during the procedure with its connection to the Lightbox via the Sled accessory.
The following provides an analysis of the acceptance criteria and study findings for the Pantheris System, based on the provided FDA 510(k) summary.
1. Table of Acceptance Criteria and Reported Device Performance
| Endpoint | Acceptance Criteria (Performance Goal) | Reported Device Performance (Pantheris System) |
|---|---|---|
| Primary Safety: Freedom from Major Adverse Events (MAE) at 30 days | MAEs occurring in 79% | 89% (86 out of 97 subjects) had 61% |
| Secondary Effectiveness: Procedural Success (residual stenosis ≤ 30% post-Pantheris + adjunctive therapy) | Not explicitly defined as a performance goal with a specific threshold. | 80% (78 out of 97 subjects) had residual stenosis |
Ask a specific question about this device
(224 days)
The Pantheris SV is intended to remove plaque (atherectomy) from partially occluded vessels in the peripheral vasculature with a reference diameter of 2.0 mm to 4.0 mm, using OCTassisted orientation and imaging. The system is an adjunct to fluoroscopy by providing images of vessel lumen, wall structures and vessel morphologies. The Pantheris SV is NOT intended for use in the iliac, coronary, cerebral, renal or carotid vasculature.
The Pantheris SV catheter is a monorail (rapid exchange) device with a working length of 144 cm, compatible with a 6 French sheath and an 0.014" guidewire. It consists of a lubricious coated torque shaft with a proximal handle assembly and an atraumatic distal assembly. The distal assembly of the catheter consists of an imaging assembly, a rotating cutter, and a flexible, tiltable nosecone. The catheter is sterilized by electron beam radiation and is intended for single use only. The Pantheris SV is to be used in a healthcare facility, such as a cardiac catheter lab or a hospital. It is to be used and in contact with patient tissue for less than 24 hours and is made of materials that are biocompatible.
This document is a 510(k) summary for the Pantheris SV atherectomy catheter. It describes the device, its intended use, and compares it to a predicate device and a reference device. It also details the non-clinical performance data supporting the device's substantial equivalence.
Here's a breakdown of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly present acceptance criteria in a tabular format for each test. Instead, it states that the device "passed all tests" or that parameters were "ranked from 'good' to 'excellent'." No specific quantitative acceptance values are provided, as this is a 510(k) submission focused on substantial equivalence rather than a detailed performance study with pre-defined statistical endpoints for a new technology.
However, based on the Mechanical Testing and Animal Testing sections, we can infer some performance indicators:
| Acceptance Criteria (Inferred from testing) | Reported Device Performance |
|---|---|
| Biocompatibility standards met | Passed all ISO 10993 tests (Cytotoxicity, Sensitization, Irritation, Material-mediated pyrogenicity, Systemic toxicity, Complement activation, Partial thromboplastin time, Platelet and leukocyte count, Hemolysis extract, Hemolysis direct) |
| Electrical safety standards met | Complies with IEC 60601-1 |
| Electromagnetic compatibility (EMC) standards met | Complies with IEC 60601-1-2 |
| Software Verification & Validation | Successfully upgraded to version 4.4.0 (for Lightbox console) |
| Mechanical integrity (e.g., Simulated use, working length, flush & leak, image generation, rotation, guidewire compatibility, insertion force, retraction force, cutter exposure, full 360° image, cut/pack cycles, coating integrity, life cycle, torque-proof loading, tensile strengths, functionality performance) | All mechanical tests performed at time 0 and 3 months. Implied successful completion as no issues are reported. |
| Animal study safety | No significant procedural adverse events, no evidence of acute vessel trauma, no evidence of thrombus, no tissue reaction (gross necropsy and histopathology). |
| Animal study performance (tracking, advancement, OCT clarity, orientation, MEFR) | All treatment evaluation parameters and MEFR evaluations ranked from "good" to "excellent." No thrombus visualized, no device failures. |
2. Sample Size Used for the Test Set and Data Provenance
- Mechanical Testing: The document does not specify the exact sample size (number of catheters/units) used for each mechanical test. It lists the types of tests conducted.
- Animal Testing: Two pigs were enrolled in this study.
- Data Provenance: The study was a GLP (Good Laboratory Practice) animal study. While the country isn't explicitly stated, GLP studies are typically highly regulated, and the context of an FDA submission suggests it was conducted under U.S. or comparable international standards. It is a prospective study for the purpose of demonstrating safety and performance.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
For the animal study, the document mentions "gross necropsy and histopathology" which would typically involve qualified veterinary pathologists. However, the number of experts or their specific qualifications (e.g., board-certified veterinary pathologist with X years of experience) are not specified in this summary. The ranking of treatment evaluation parameters from "good" to "excellent" implies expert assessment, but the details are missing.
4. Adjudication Method for the Test Set
The document does not describe any adjudication method for the animal study or mechanical testing. Given the summary's content, it's likely that a single expert or a team within the company assessed the results of the animal study, but no formal adjudication process (like 2+1 or 3+1 consensus) is outlined.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The submission explicitly states: "No clinical testing of the subject device was necessary." The testing involved mechanical and animal studies.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
The Pantheris SV catheter incorporates Optical Coherence Tomography (OCT) for imaging, and the "Lightbox Console" has software (version 4.4.0). The device is characterized as "OCT-assisted orientation and imaging" with the system acting "as an adjunct to fluoroscopy." This implies human interaction/interpretation of the OCT images for directional atherectomy. Therefore, a purely standalone algorithm without human-in-the-loop performance cannot be definitively inferred from this document as the primary mode of operation. The "Imaging Capabilities" section describes the system as one to "facilitate atherectomy" and "identify clinically relevant morphologies," which suggests human interpretation of the images provided by the device.
7. The Type of Ground Truth Used
- Mechanical Testing: Ground truth is established by engineering specifications, standardized test methods (e.g., BS EN 1707:1997, ISO 10555-1:2013), and direct physical measurement/observation against those specifications.
- Animal Testing: Ground truth for safety was established by gross necropsy and histopathology performed by veterinary professionals (implied, though not explicitly stated as "experts"). Ground truth for performance was based on direct observation during the procedure and subsequent evaluation/ranking by the study team.
8. The Sample Size for the Training Set
This document describes a 510(k) submission for a medical device (atherectomy catheter with OCT imaging). It is not an AI/Machine Learning submission where a training set of data for an algorithm would be used in the conventional sense. The "Software Verification and Validation Testing" refers to the Lightbox component's software, but this typically involves testing the software against functional requirements and software design specifications, not training an AI model with a data set. Therefore, a "training set" as understood in AI systems is not applicable to this submission.
9. How the Ground Truth for the Training Set Was Established
As explained in point 8, a "training set" for an AI model is not applicable to this submission. The "ground truth" for the device's functional software would be its adherence to documented software requirements and design specifications, established through V&V activities.
Ask a specific question about this device
Page 1 of 1